References
1. Obedinsky A.A., Obedinskaya N.R., Nikitin N.A., Sirota D.A., Krest’yaninov O.V. Multivessel coronary disease in patients with stable coronary heart disease: current state of the problem and gaps in evidence. Sibirskiy zhurnal klinicheskoy i eksperimental’noy meditsiny [Siberian Journal of Clinical and Experimental Medicine]. 2022; 37 (2): 28–34. DOI: https://doi.org/10.29001/2073-8552-2022-37-2-28-34 (in Russian)
2. Vereshchagin I.E., Ganyukov V.I., Tarasov R.S., Kornelyuk R.A. Analysis of in-hospital and long-term results of percutaneous coronary intervention with extracorporeal membrane oxygenation support in patients with coronary heart disease. Kompleksnye problemy serdechno-sosudistykh zabolevaniy [Complex Problems of Cardiovascular Diseases]. 2021; 10 (4): 96–105. DOI: https://doi.org/10.17802/2306-1278-2021-10-4-96-105 (in Russian)
3. Bugaenko D.V., Fominykh M.V., Eremenko A.A. Modern left ventricular assist devices installed through percutaneous access. Kardiologiya i serdechno-sosudistaya khirurgiya [Cardiology and Cardiovascular Surgery]. 2018; 11 (3): 35–40. DOI: https://doi.org/10.17116/kardio201811335 (in Russian)
4. O’Neill W.W., Kleiman N.S., Moses J., Henriques J.P., Dixon S., Massaro J., et al. A prospective randomized clinical trial of hemodynamic support with Impella 2.5 TM versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 2012; 126 (14): 1717–27.
5. Lauten A., Engström A.E., Jung C., Empen K., Erne P., Cook S., et al. Percutaneous left ventricular support with the Impella 2.5 assist device in acute cardiogenic shock – results of the Impella EUROSHOCK-Registry. Circ Heart Fail. 2013; 6 (1): 23–30. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.112.967224
6. Ganyukov V.I., Shukevich D.L., Khaes B.L., Kochergin N.A., Popov V.A., Barbarash L.S. In-hospital and long-term results of percutaneous coronary intervention with biventricular support with extracorporeal membrane oxygenation. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2015; 6 (122): 81–6. DOI: https://doi.org/10.15829/1560-4071-2015-06-81-86 (in Russian)
7. Gushchina A.S., Sesina A.A., Shopova Yu.A. A rare complication of extracorporeal membrane oxygenation. Vestnik soveta molodykh uchenykh i spetsialistov Chelyabinskoy oblasti [Bulletin of the Council of Young Scientists and Specialists of Chelyabinsk Region]. 2018; 4 (1): 29–31. (in Russian)
8. Zhang H., Xu J., Yang X., Zou X., Shu H., Liu Z., et al. Narrative review of neurologic complications in adults on ECMO: prevalence, risks, outcomes, and prevention strategies. Front Med (Lausanne). 2021; 8: 713333. DOI: https://doi.org/10.3389/fmed.2021.713333
9. Bastos M.B., van Wiechen M.P., Van Mieghem N.M. PulseCath iVAC2L: next-generation pulsatile mechanical circulatory support. Future Cardiol. 2020; 16 (2): 103–12. DOI: https://doi.org/10.2217/fca-2019-0060
10. Chieffo A., Dudek D., Hassager C., Combes A., Gramegna M., Halvorsen S., et al. Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices. Eur Heart J Acute Cardiovasc Care. 2021; 10 (5): 570–83. DOI: https://doi.org/10.1093/ehjacc/zuab015
11. Park S.J., Ahn J.M., Kim Y.H., Park D.W., Yun S.C., Lee J.Y., et al.; BEST Trial Investigators. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med. 2015; 372: 1204–12.
12. Bastos M.B., McConkey H., Malkin O., den Uil C., Daemen J., Patterson T., et al. Effect of next generation pulsatile mechanical circulatory support on cardiac mechanics: the PULSE trial. Cardiovasc Revasc Med. 2022; 42: 133–42. DOI: https://doi.org/10.1016/j.carrev.2022.03.013
13. Samol A., Schmidt S., Zeyse M., Wiemer M., Luani B. High-risk PCI under support of a pulsatile left ventricular assist device – First German experience with the iVAC2L system. Int J Cardiol. 2019; 297: 30–5. DOI: https://doi.org/10.1016/j.ijcard.2019.10.020
14. Dzemeshkevich S.L., Babaev M.A., Frolova Yu.V., Malikova M.S., Lugovoy A.N., Dombrovskaya A.V., et al. Non-compact left ventricular myocardium, reverse cardiac remodeling and assisted systolic support with PulseCath. Clinical and Experimental Surgery. Petrovsky Journal. 2017; (1): 15–21. DOI: https://doi.org/10.24411/2308-1198-2017-00015 (in Russian)
15. Alekyan B.G., Karapetyan N.G., Novak A.Ya., Plotnikov G.P., Knysh Yu.B., Grigoryan G.S. A case of the first use in Russia of the PulseCath iVAC 2L circulatory support device during high-risk percutaneous coronary intervention. Kompleksnye problemy serdechno-sosudistykh zabolevaniy [Complex Problems of Cardiovascular Diseases]. 2020; 9 (1): 103–9. DOI: https://doi.org/10.17802/2306-1278-2020-9-1-103-109 (in Russian)
16. URL: https://cardioweb.ru/news/item/3923-zashchishchennoe-stentirovanie-koronarnykh-arterij-s-ispolzovaniem-sistemy-vspomogatelnogo-krovoobrashcheniya-novye-vozmozhnosti-dlya-patsientov-s-ishemicheskoj-boleznyu-serdtsa-i-krajne-vysokim-operativnymi-riskom
17. Bugaenko D.V., Fominykh M.V., Eremenko A.A. Modern left ventricular assist devices installed through percutaneous access. Kardiologiya i serdechno-sosudistaya khirurgiya [Cardiology and Cardiovascular Surgery]. 2018; (3): 35–40. (in Russian)
18. Ganyukov V.I., Shilov A.A. Modern approaches to myocardial revascularization in cardiogenic shock. Endovaskulyarnaya khirurgiya [Endovascular surgery]. 2015; 3 (2): 5–15. (in Russian)
19. Neverova Yu.N., Golovina T.S., Tarasov R.S. Intra-aortic balloon counterpulsation: current evidence base and unresolved issues. Patologiya krovoobrashcheniya i kardiokhirurgiya [Pathology of Blood Circulation and Cardiac Surgery]. 2020; 24 (3S): 18–32. (in Russian)
20. Vereshchagin I.E., Ganyukov V.I., Kochergin N.A., Kornelyuk R.A., Barbarash O.L. Results of percutaneous intervention in acute coronary syndrome depending on the type of mechanical hemodynamic circulatory support. Patologiya krovoobrashcheniya i kardiokhirurgiya [Pathology of Blood Circulation and Cardiac Surgery]. 2019; 23 (1S): 34–43. (in Russian)